This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Multiple Sclerosis/ Demyelinating Disease  • Neurology, Other  • Radiologic Imaging  • Prognosis/ Outcomes  • Magnetic Resonance Imaging  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Susan A. Gauthier, DO, MPH; Annika M. Berger, MD; Zsuzsanna Liptak, MD; Yang Duan, MD; Svetlana Egorova, MD, PhD; Guy J. Buckle, MD; Bonnie I. Glanz, PhD; Samia J. Khoury, MD; Rohit Bakshi, MD; Howard L. Weiner, MD; Charles R. G. Guttmann, MD

Arch Neurol. 2009;66(2):234-237.

Background  Benign multiple sclerosis (MS) is defined by minimal or no disability after many years of observation, therefore a less degenerative disease process is suspected to be present in this subset of patients.

Objective  To compare brain atrophy rates in patients with long-standing benign MS vs typical early MS.

Design  A longitudinal prospective cohort study and a retrospective database review.

Setting  An academic MS center.

Patients  Thirty-nine patients with clinically defined benign MS and an age-matched group of 40 patients with early relapsing-remitting MS.

Main Outcome Measures  Baseline demographic, treatment, brain magnetic resonance imaging measures, and annualized atrophy rates, derived from serial brain parenchymal fraction measurements across 2 years, were compared.

Results  In the baseline analysis, patients with benign MS were matched to the early MS group on age, sex, treatment with immunomodulatory therapy, T2 lesion volume, and brain parenchymal fraction. The mean (SD) annualized brain atrophy rate in patients with benign MS (–0.16% [0.51%]) was lower than that in patients with early MS (–0.46% [0.72%]) (P = .02). The difference remained significant after controlling for age, sex, and treatment (P = .04).

Conclusions  Serial magnetic resonance imaging revealed a low 2-year rate of brain atrophy in patients with clinically benign MS, suggesting a less prominent degenerative component in its pathogenesis than in patients with typical early MS. Identification of patients with a low rate of brain atrophy may indicate a benign course.

Author Affiliations: Department of Neurology, Partners Multiple Sclerosis Center (Drs Gauthier, Buckle, Glanz, Khoury, and Weiner), and Department of Radiology (Drs Berger, Liptak, Duan, Egorova, Bakshi, and Guttmann), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Dr Gauthier is now with the Judith Jaffe Multiple Sclerosis Center, Weill Cornell Medical College, New York, New York.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(2):151-152.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway
Glad et al.
Mult Scler 2009;15:942-950.
ABSTRACT